Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 70.84% is 190% above its 5-year average of 24.40%, near the high end of its 5-year range (2.23%–74.84%).
As of the fiscal period ended Tuesday, June 30, 2026. 9.77% above its 12-month average of 64.53%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 70.84%.
DEBT TO ASSETS RATIO
70.84%
DEBT TO ASSETS RATIO AVG TTM
64.53%
DEBT TO ASSETS RATIO AVG 3Y
36.87%
DEBT TO ASSETS RATIO AVG 5Y
24.40%
DEBT TO ASSETS RATIO AVG 10Y
6.66%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+9.77%
CURRENT VS 3Y AVG
+92.12%
CURRENT VS 5Y AVG
+190.27%
CURRENT VS 10Y AVG
+963.97%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+78609.74%
vs the sector median at left
Ocugen, Inc.
Market Cap
$352.67M
Debt to Assets Ratio
70.84%
TTM Avg
64.53%
3Y Avg
36.87%
5Y Avg
24.40%
Market Cap
$353.88M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$355.36M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$355.43M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$349.70M
Debt to Assets Ratio
0.61%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$346.73M
Debt to Assets Ratio
0.36%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$359.53M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$344.04M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ocugen, Inc. (OCGN) | $352.67M | 70.84% | 64.53% | 36.87% | 24.40% |
| Embecta Corp. (EMBC)vs › | $353.00M | 1.19% | N/A | N/A | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.88M | 0.19% | N/A | N/A | N/A |
| Viemed Healthcare, Inc. (VMD)vs › | $355.36M | 0.06% | N/A | N/A | N/A |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | 0.03% | N/A | N/A | N/A |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.70M | 0.61% | N/A | N/A | N/A |
| Turn Therapeutics Inc. (TTRX)vs › | $346.73M | 0.36% | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | 0.00% | N/A | N/A | N/A |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | 0.00% | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | 0.38% | N/A | N/A | N/A |
Debt/Assets
70.8%
Debt/Equity
N/A
Current Ratio
0.80
Interest Coverage
-12.1x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 70.84% |
| 2026-03-31 | 58.51% |
| 2025-12-31 | 74.84% |
| 2025-09-30 | 57.23% |
| 2025-06-30 | 61.24% |
| 2025-03-31 | 49.37% |
| 2024-12-31 | 39.43% |
| 2024-09-30 | 10.95% |
| 2024-06-30 | 16.93% |
| 2024-03-31 | 13.19% |
| 2023-12-31 | 10.75% |
| 2023-09-30 | 8.67% |
| 2023-06-30 | 7.39% |
| 2023-03-31 | 6.52% |
| 2022-12-31 | 5.87% |
| 2022-09-30 | 5.57% |
| 2022-06-30 | 4.58% |
| 2022-03-31 | 2.23% |
| 2021-12-31 | 3.13% |
| 2021-09-30 | 2.70% |
| 2021-06-30 | 2.55% |
| 2021-03-31 | 6.71% |
| 2020-12-31 | 9.10% |
| 2020-09-30 | 16.37% |
| 2020-06-30 | 26.68% |
| 2020-03-31 | 15.22% |
| 2019-12-31 | 8.38% |
| 2019-09-30 | 6.23% |
| 2019-06-30 | 106.20% |
| 2019-03-31 | 7.53% |
| 2018-12-31 | 1.37% |
| 2018-09-30 | 2.19% |
| 2018-06-30 | 1.57% |
| 2018-03-31 | 0.21% |
| 2017-12-31 | 1.61% |
| 2017-09-30 | 2.05% |
| 2017-06-30 | 2.12% |
| 2017-03-31 | 2.17% |
| 2016-12-31 | 2.11% |
| 2016-09-30 | 2.12% |
| 2016-06-30 | 4.95% |
| 2016-03-31 | 4.20% |
| 2015-12-31 | 3.65% |
| 2015-09-30 | 3.29% |
| 2015-06-30 | 3.07% |
| 2015-03-31 | 2.82% |
| 2014-12-31 | 2.67% |
| 2014-09-30 | 3.57% |
| 2014-06-30 | 0.00% |
| 2013-12-31 | 0.00% |
